Rand Paul

A renewed debate over gain-of-function research, overseas biological laboratories, and government transparency is gaining momentum after Director of National Intelligence Tulsi Gabbard declassified documents detailing U.S.-supported biological research programs worldwide.

The newly released information has reignited questions that first surfaced during the COVID-19 pandemic about the extent of American involvement in overseas laboratories studying dangerous pathogens and whether federal officials were fully transparent with the public about those programs.

Among those leading the push for further investigation is Kentucky Senator Rand Paul, who has spent years clashing with former National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci over gain-of-function research and the origins of COVID-19.

Speaking with The National News Desk, Paul argued that the declassified documents confirm concerns that many public officials and media outlets previously dismissed.

"For years, when people pointed out that these labs existed in places like Ukraine, they were told it was a conspiracy theory," Paul said. "Now we're finding out they did exist."

According to Gabbard, the newly declassified documents show that the United States supported or funded more than 120 biological laboratories across more than 30 countries, including facilities in Ukraine that worked with potentially dangerous pathogens.

Paul said the revelations raise concerns not only about the existence of the labs but also about the type of research being conducted inside them.

The senator argued that some research projects may have been moved overseas because they would have generated greater scrutiny if conducted inside the United States.

"Some of the research we believe is farmed out to foreign countries because they know it's dangerous and they know there would be objections if it were done on American soil," Paul said.

The debate centers largely on gain-of-function research, a controversial area of science that involves modifying pathogens to better understand how they spread, evolve, or infect hosts.

Supporters argue the research can help scientists prepare for future outbreaks and develop treatments or vaccines. Critics contend that altering viruses can create significant risks if those pathogens escape containment.

Paul said his concern is not with all biological research but with experiments that increase the transmissibility or danger posed by viruses.

He pointed specifically to concerns about research involving avian influenza and coronaviruses.

"We don't want to be supporting a lab somewhere that is taking a virus and making it more adapted to humans," Paul said. "That's what they were doing in Wuhan."

The senator also pushed back against claims that many of the overseas facilities were publicly disclosed and never hidden from public view.

Critics of Paul's position note that some Pentagon-supported biological research programs and cooperative threat-reduction initiatives have been publicly documented for years.

Paul responded that while information about some facilities eventually became public, officials frequently dismissed concerns about them during the height of the COVID-era debate.

"When people first raised these questions, they were told these programs didn't exist," he said. "Now that the documents are out, we're hearing a different story."

Beyond the laboratories themselves, Paul accused elements of the intelligence community and federal bureaucracy of obstructing congressional oversight efforts.

The senator described repeated difficulties obtaining classified records and information related to intelligence and biological research programs.

"They hide things because they don't want scrutiny," Paul said.

According to Paul, lawmakers should be able to review specific experiments and determine whether they constitute gain-of-function research rather than relying on agency definitions.

Throughout the interview, Paul also revisited his long-running criticism of Dr. Anthony Fauci.

Paul argued that federal agencies repeatedly narrowed or redefined the meaning of gain-of-function research during the pandemic debate.

According to the senator, officials often relied on technical distinctions that allowed them to argue certain experiments did not meet formal definitions of gain-of-function despite involving modifications to viruses.

"All of these are gain-of-function experiments," Paul said.

The Kentucky Republican is now calling for the creation of a presidential commission that would review biological research projects both domestically and internationally before they move forward.

Under his proposal, scientists would evaluate research involving dangerous pathogens and determine whether the potential risks outweigh the benefits.

"What I'm proposing is a presidential commission with scientists to review all research from here forward and scrutinize whether or not it is gain-of-function," Paul said.

The senator also questioned the legal durability of former President Joe Biden's pardon for Fauci.

Paul argued that the pardon could face legal challenges because it broadly covers potential conduct over an extended period without being tied to specific charges.

Legal scholars remain divided on whether such a challenge would succeed, and no court has yet ruled on the scope of the pardon.

As lawmakers continue reviewing Gabbard's newly released documents, the broader debate over gain-of-function research, pandemic preparedness, and government transparency appears far from over.

Paul said the next step is examining the research itself, lab by lab and pathogen by pathogen.

"We're going to go lab by lab," he said. "We're going to expose the individual pathogens they're using and the dangers involved."

With congressional investigations expected to continue and additional records potentially forthcoming, the issue is likely to remain a flashpoint in the ongoing effort to understand how biological research is conducted, funded, and monitored around the world.